"Designing Growth Strategies is in our DNA"

Intravenous Immunoglobulin Market Size, Share & Industry Analysis By Indication (Primary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Guillain-Barré Syndrome (GBS), Immune Thrombocytopenic Purpura (ITP), Multifocal Motor Neuropathy (MMN)), Form (Liquid, Lyophilized), End User (Hospitals, Clinics, Homecare) & Regional Forecast, 2018 - 2025

Region : Global | Format: PDF | Report ID: FBI100593

 

Table of Content:

1.     Introduction

1.1.  Research Scope

1.2.  Market Segmentation

1.3.  Research Methodology

1.4.  Definitions and Assumptions

2.     Executive Summary

3.     Market Dynamics

3.1.  Market Drivers

3.2.  Market Restraints

3.3.  Market Opportunities

4.     Key Insights

4.1.  Pipeline Analysis

4.2.  Overview of Regulatory Scenario by Key Regions

4.3.  Key Industry Developments

4.4.  Number (Estimated) of Primary Immunodeficiency (PI) Patients by Key Countries

4.5.  Overview of Reimbursement Scenario

5.     Global Intravenous Immunoglobulin Market Analysis, Insights and Forecast, 2015-2025

5.1.  Key Findings /Summary

5.2.  Market Analysis, Insights and Forecast – By Indication

5.2.1.     Primary Immunodeficiency

5.2.2.     Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

5.2.3.     Guillain-Barré Syndrome (GBS)

5.2.4.     Immune Thrombocytopenic Purpura (ITP)

5.2.5.     Multifocal Motor Neuropathy (MMN)

5.2.6.     Others

5.3.  Market Analysis, Insights and Forecast – By Form

5.3.1.     Liquid

5.3.2.     Lyophilized

5.4.  Market Analysis, Insights and Forecast – By End User

5.4.1.     Hospitals

5.4.2.     Clinics

5.4.3.     Homecare

5.5.  Market Analysis, Insights and Forecast – By Region

5.5.1.     North America

5.5.2.     Europe

5.5.3.     Asia Pacific

5.5.4.     Latin America

5.5.5.     Middle East & Africa

6.     North America Intravenous Immunoglobulin Market Analysis,Insights and Forecast, 2015-2026

6.1.  Key Findings / Summary

6.2.  Market Analysis – By Indication

6.2.1.     Primary Immunodeficiency

6.2.2.     Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

6.2.3.     Guillain-Barré Syndrome (GBS)

6.2.4.     Immune Thrombocytopenic Purpura (ITP)

6.2.5.     Multifocal Motor Neuropathy (MMN)

6.2.6.     Others

6.3.  Market Analysis – By Form

6.3.1.     Liquid

6.3.2.     Lyophilized

6.4.  Market Analysis – By End User

6.4.1.     Hospitals

6.4.2.     Clinics

6.4.3.     Homecare

6.5.  Market Analysis – By Country

6.5.1.     U.S.

6.5.2.     Canada

7.     Europe Intravenous Immunoglobulin Market Analysis, Insights and Forecast, 2015-2026

7.1.  Key Findings / Summary

7.2.  Market Analysis – By Indication

7.2.1.     Primary Immunodeficiency

7.2.2.     Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

7.2.3.     Guillain-Barré Syndrome (GBS)

7.2.4.     Immune Thrombocytopenic Purpura (ITP)

7.2.5.     Multifocal Motor Neuropathy (MMN)

7.2.6.     Others

7.3.  Market Analysis – By Form

7.3.1.     Liquid

7.3.2.     Lyophilized

7.4.  Market Analysis – By End User

7.4.1.     Hospitals

7.4.2.     Clinics

7.4.3.     Homecare

7.5.  Market Analysis – By Country/ Sub-Region

7.5.1.     U.K.

7.5.2.     Germany

7.5.3.     France

7.5.4.     Spain

7.5.5.     Italy

7.5.6.     Scandinavia

7.5.7.     Rest of Europe

8.     Asia Pacific Intravenous Immunoglobulin Market Analysis, Insights and Forecast, 2015-2026

8.1.  Key Findings / Summary

8.2.  Market Analysis – By Indication

8.2.1.     Primary Immunodeficiency

8.2.2.     Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

8.2.3.     Guillain-Barré Syndrome (GBS)

8.2.4.     Immune Thrombocytopenic Purpura (ITP)

8.2.5.     Multifocal Motor Neuropathy (MMN)

8.2.6.     Others

8.3.  Market Analysis – By Form

8.3.1.     Liquid

8.3.2.     Lyophilized

8.4.  Market Analysis – By End User

8.4.1.     Hospitals

8.4.2.     Clinics

8.4.3.     Homecare

8.5.  Market Analysis – By Country/ Sub-Region

8.5.1.     Japan

8.5.2.     China

8.5.3.     India

8.5.4.     Australia

8.5.5.     Southeast Asia

8.5.6.     Rest of Asia Pacific

9.     Latin America Intravenous Immunoglobulin Market Analysis,Insights and Forecast, 2015-2026

9.1.  Key Findings / Summary

9.2.  Market Analysis – By Indication

9.2.1.     Primary Immunodeficiency

9.2.2.     Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

9.2.3.     Guillain-Barré Syndrome (GBS)

9.2.4.     Immune Thrombocytopenic Purpura (ITP)

9.2.5.     Multifocal Motor Neuropathy (MMN)

9.2.6.     Others

9.3.  Market Analysis – By Form

9.3.1.     Liquid

9.3.2.     Lyophilized

9.4.  Market Analysis – By End User

9.4.1.     Hospitals

9.4.2.     Clinics

9.4.3.     Homecare

9.5.  Market Analysis – By Country/ Sub-Region

9.5.1.     Brazil

9.5.2.     Mexico

9.5.3.     Rest of Latin America

10.  Middle East &Africa Intravenous Immunoglobulin Market Analysis, Insights and Forecast,2015-2026

10.1.    Key Findings / Summary

10.2.     Market Analysis –By Indication

10.2.1. Primary Immunodeficiency

10.2.2. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

10.2.3. Guillain-Barré Syndrome (GBS)

10.2.4. Immune Thrombocytopenic Purpura (ITP)

10.2.5. Multifocal Motor Neuropathy (MMN)

10.2.6. Others

10.3.     Market Analysis –By Form

10.3.1. Liquid

10.3.2. Lyophilized

10.4.    Market Analysis – By End User

10.4.1. Hospitals

10.4.2. Clinics

10.4.3. Homecare

10.5.    Market Analysis – By Country/ Sub-Region

10.5.1. GCC Countries

10.5.2. South Africa

10.5.3. Rest of Middle East & Africa

11.  Competitive Analysis

11.1.     Key Industry Developments

11.2.     Global Market Share Analysis (2018)

11.3.     Competition Dashboard

11.4.     Comparative Analysis – Major Players

11.5.    Company Profiles (Overview, Products& Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))

11.5.1. Shire (Takeda Pharmaceutical Company Limited)

11.5.2. CSL Behring

11.5.3. Grifols, S.A.

11.5.4. Kedrion S.p.A

11.5.5. Octapharma

11.5.6. Bio Products Laboratory Ltd.

11.5.7. Biotest AG

11.5.8. China Biologic Products Holdings, Inc.

11.5.9. LFB SA

11.5.10. Shanghai RAASBlood Products Co., Ltd.

 

12.  Strategic Recommendations

  • Jun, 2019
  • 2017
  • 2014-2016
  • 145

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850
    Book Now

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X